Skip to main content
. 2016 Aug 15;8(8):635–641. doi: 10.4251/wjgo.v8.i8.635

Figure 6.

Figure 6

In pancreatic adenocarcinoma patients with coexisting diabetes mellitus, transforming growth factor-β1 serum level was significantly higher than in pancreatic adenocarcinoma patients without endocrine insufficiency. TGF-β1: Transforming growth factor-β1.